Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Estrogen receptor β and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer.

Mauro LV, Dalurzo M, Carlini MJ, Smith D, Nuñez M, Simian M, Lastiri J, Vasallo B, Bal de Kier Joffé E, Pallotta MG, Puricelli L.

Oncol Rep. 2010 Nov;24(5):1331-8.

PMID:
20878128
2.

[Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].

Mauro LV, Dalurzo M, Smith D, Lastiri J, Vasallo B, Joffei EB, Pallotta MG, Puricelli L.

Medicina (B Aires). 2008;68(3):205-12. Spanish.

PMID:
18689151
3.

Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.

Cortas T, Eisenberg R, Fu P, Kern J, Patrick L, Dowlati A.

Lung Cancer. 2007 Mar;55(3):349-55. Epub 2006 Dec 8.

PMID:
17161498
4.

Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer.

Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Ogawa J.

Anticancer Res. 2005 Nov-Dec;25(6C):4693-8.

5.

Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?

Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.

APMIS. 2009 Sep;117(9):644-50. doi: 10.1111/j.1600-0463.2009.02510.x.

PMID:
19703124
6.

Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.

Milas I, Komaki R, Hachiya T, Bubb RS, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L.

Clin Cancer Res. 2003 Mar;9(3):1070-6.

7.
8.

Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.

Cox G, Louise Jones J, Andi A, Abrams KR, O'Byrne KJ.

Lung Cancer. 2001 Dec;34(3):417-26.

PMID:
11714539
9.

Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.

Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J.

Clin Cancer Res. 2005 Jul 15;11(14):5084-9.

10.

Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.

Skov BG, Fischer BM, Pappot H.

Lung Cancer. 2008 Jan;59(1):88-94. Epub 2007 Oct 1.

PMID:
17905466
11.

Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.

Timotheadou E, Skarlos DV, Samantas E, Papadopoulos S, Murray S, Skrickova J, Christodoulou C, Papakostantinou C, Pectasides D, Papakostas P, Kaplanova J, Vrettou E, Karina M, Kosmidis P, Fountzilas G.

Anticancer Res. 2007 Nov-Dec;27(6C):4481-9.

12.

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.

Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF.

Hum Pathol. 2002 Jan;33(1):105-10.

PMID:
11823980
13.

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.

Nose N, Sugio K, Oyama T, Nozoe T, Uramoto H, Iwata T, Onitsuka T, Yasumoto K.

J Clin Oncol. 2009 Jan 20;27(3):411-7. doi: 10.1200/JCO.2008.18.3251. Epub 2008 Dec 8.

PMID:
19064969
14.

Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.

Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J.

Clin Lung Cancer. 2012 Sep;13(5):375-84. doi: 10.1016/j.cllc.2011.11.006. Epub 2012 Jan 27.

PMID:
22284440
16.
17.

Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.

Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.

Cancer Res. 1997 Feb 1;57(3):433-9.

18.

[Epidermal growth factor receptor and phosphorylated Akt protein expression in non-small-cell lung cancer].

Zhou ZL, Yang F, Jiang GC, Huang YQ, Fu J, Wang J.

Zhonghua Yi Xue Za Zhi. 2008 Apr 15;88(15):1062-5. Chinese.

PMID:
18754442
19.

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR.

J Clin Oncol. 2004 Nov 15;22(22):4575-83.

PMID:
15542809
20.

Supplemental Content

Support Center